BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Response to oxidative stress
,
Breast Cancer
,
Hypothalamus
,
Laryngoscope
,
Rapamycin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
serpine1 protein, human
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Corpus lutea from hCG treated macaques depleted of steroids
Glioblastoma LN18 cells with KPC1 (RNF123) gene overexpression
Coronary artery smooth muscle cells with SMAD3 siRNA knockdown
Explore Curated Studies Results
Literature
Most Relevant Literature
Association of SNPs in the PAI1 Gene with Disease Recurrence and Clinical Outcome in Bladder Cancer.
Association of the metabolic syndrome with PAI 1act and clot lysis time over a 10-year follow up in …
Good or bad: Paradox of plasminogen activator inhibitor 1 (PAI-1) in digestive system tumors.
Past, Present, and Future Perspectives of Plasminogen Activator Inhibitor 1 (PAI-1).
Data mining combines bioinformatics discover immunoinfiltration-related gene SERPINE1 as a biomarker…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Digoxin for Congenital Erythrocytosis Due to Up-Regulated Hypoxia Sensing
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ